Tanja Obradovic: Asia Biotech companies are driving major advances in oncology this year

Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, posted on LinkedIn:

“Asia Biotech companies are driving major advances in Oncology this year. In Oncology ADCs, one of large collaborations happened just few months ago – China’s GeneQuantum Healthcare and South Korea’s Aimed Bio are expanded their partnership to encompass up to five more therapies.

Besides generating many clinical candidates especially in immunooncology it is clinical development that is also advancing rapidly. Among recent news very important milestone just happened few days ago. Suzhou CStone Pharma got approval for anti PD-L1 mAb for the 1st line in esophageal squamous cell carcinoma in China. Congrats Suzhou team on your fourth approval in China!”

To read more click here.
Source: Tanja Obradovic/LinkedIn